Chochola J, Fabre C, Bellan C, Luis J, Bourgerie S, Abadie B, Champion S, Marvaldi J, el Battari A
Centre National de la Recherche Scientifique URA 202, Université d'Aix-Marseille, France.
J Biol Chem. 1993 Feb 5;268(4):2312-8.
The vasoactive intestinal peptide (VIP) receptor from the human melanoma cell line IGR39 has been shown to be a 60-kDa glycoprotein. Using serial lectin affinity chromatography, as well as specific glycosidases, we demonstrate that VIP receptor-linked carbohydrates are predominantly tri- or tetraantennary sialylated N-linked oligosaccharides, 27% of which are fucosylated, and some may have terminal galactose residues. Treatment of 125I-VIP receptor complexes with peptide-N4-(N-acetyl-beta-D-glucosaminyl)asparagine amidase revealed the presence of at least three N-linked carbohydrate chains/receptor polypeptide. To investigate the functional role of the carbohydrate moiety, 125I-VIP binding to IGR39 cell membranes was tested in the presence of soluble lectins. Among the lectins tested, only wheat germ agglutinin (WGA) was found to markedly inhibit VIP binding in a dose-dependent manner. Binding data indicated that the presence of the lectin led to a 3-fold increase in Kd value, from 0.15 to 0.44 nM, without any change in the number of available binding sites. The potent inhibitor of WGA binding, N,N',N"-triacetylchitotriose, completely reversed the effect of the lectin. On the other hand, VIP binding inhibition persisted even after neuraminidase treatment, suggesting that sialic acids were not directly involved. Furthermore, WGA inhibition was not abolished although most, if not all, VIP receptor oligosaccharides were converted to high mannose type structures by treating IGR39 cells with deoxymannojirimycin. Finally, whereas the pharmacological profile of VIP receptor was virtually identical, the presence of WGA greatly reduced the VIP-stimulated cAMP in IGR39 cells, indicating that the lectin alters the ability of the receptor to interact with the adenylate cyclase system.
人黑色素瘤细胞系IGR39中的血管活性肠肽(VIP)受体已被证明是一种60 kDa的糖蛋白。通过连续凝集素亲和层析以及特定糖苷酶,我们证明与VIP受体相连的碳水化合物主要是三天线或四天线唾液酸化的N - 连接寡糖,其中27%被岩藻糖基化,有些可能含有末端半乳糖残基。用肽 - N4 -(N - 乙酰 - β - D - 葡糖胺基)天冬酰胺酶处理125I - VIP受体复合物,发现至少存在三条N - 连接碳水化合物链/受体多肽。为了研究碳水化合物部分的功能作用,在可溶性凝集素存在的情况下测试了125I - VIP与IGR39细胞膜的结合。在所测试的凝集素中,仅发现麦胚凝集素(WGA)以剂量依赖性方式显著抑制VIP结合。结合数据表明,凝集素的存在导致Kd值增加3倍,从0.15 nM增加到0.44 nM,而可用结合位点的数量没有任何变化。WGA结合的强效抑制剂N,N',N'' - 三乙酰壳三糖完全逆转了凝集素的作用。另一方面,即使经过神经氨酸酶处理,VIP结合抑制仍然存在,这表明唾液酸不直接参与其中。此外,尽管用脱氧甘露基野尻霉素处理IGR39细胞后,大部分(如果不是全部)VIP受体寡糖都转化为高甘露糖型结构,但WGA抑制作用并未消除。最后,尽管VIP受体的药理学特征几乎相同,但WGA的存在大大降低了IGR39细胞中VIP刺激的cAMP,表明凝集素改变了受体与腺苷酸环化酶系统相互作用的能力。